Page last updated: 2024-08-24

anisodamine and ST Elevated Myocardial Infarction

anisodamine has been researched along with ST Elevated Myocardial Infarction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, M; Niu, X; Peng, Y; Sun, S; Zhang, J; Zhang, Z1
Fan, WZ; Fan, YM; Fu, XH; Fu, Y; Gu, XS; Hao, GZ; Jiang, YF; Li, YJ; Wei, QM1
Bai, S; Bi, X; Fan, Y; Fu, X; Gu, X; Li, W; Wang, Y; Wei, L1

Reviews

1 review(s) available for anisodamine and ST Elevated Myocardial Infarction

ArticleYear
Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    BMC cardiovascular disorders, 2018, 01-10, Volume: 18, Issue:1

    Topics: Aged; Bayes Theorem; Coronary Circulation; Female; Humans; Male; Middle Aged; No-Reflow Phenomenon; Odds Ratio; Percutaneous Coronary Intervention; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Treatment Outcome; Vasodilator Agents

2018

Trials

2 trial(s) available for anisodamine and ST Elevated Myocardial Infarction

ArticleYear
Comparison of myocardial microcirculatory perfusion after catheter-administered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with ST-elevation myocardial infarction.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2019, 02-15, Volume: 93, Issue:S1

    Topics: Aged; Cardiac Catheterization; China; Coronary Circulation; Coronary Thrombosis; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Male; Microcirculation; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Risk Factors; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Thrombectomy; Thrombolytic Therapy; Time Factors; Treatment Outcome; Urokinase-Type Plasminogen Activator; Vascular Patency

2019
Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.
    Coronary artery disease, 2016, Volume: 27, Issue:4

    Topics: Aged; Cardiovascular Agents; China; Coronary Angiography; Coronary Circulation; Coronary Vessels; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Perfusion Imaging; Percutaneous Coronary Intervention; Solanaceous Alkaloids; ST Elevation Myocardial Infarction; Stents; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left

2016